ADDF Launches New Phase of $150 Million Diagnostics Accelerator Initiative to Power Next Generation of Alzheimer’s Precision Medicine Worldwide

Alzheimer’s Drug Discovery Foundation Appoints Isobel Coleman as Chief Executive Officer to Lead Next Era of Alzheimer’s Breakthroughs

Alzheimer’s Drug Discovery Foundation to Present Palm Beach Symposium with Leading Scientist on Breakthrough Biomarkers in Alzheimer’s Disease